Remote intensive management to improve antiplatelet adherence in acute myocardial infarction: a secondary analysis of the randomized controlled IMMACULATE trial
-
Published:2024-02-01
Issue:
Volume:
Page:
-
ISSN:1573-742X
-
Container-title:Journal of Thrombosis and Thrombolysis
-
language:en
-
Short-container-title:J Thromb Thrombolysis
Author:
Sim Hui WenORCID, Koh Karen W. L., Poh Sock-Cheng, Chan Siew Pang, Marchesseau Stephanie, Singh Devinder, Han Yiying, Ng Faclin, Lim Eleanor, Prabath Joseph F., Lee Chi-Hang, Chen Ruth, Carvalho Leonardo, Tan Sock-Hwee, Loh Joshua P. Y., Tan Jack W. C., Kuwelker Karishma, Amanullah R. M., Chin Chee-Tang, Yip James W. L., Lee Choy-Yee, Gan Juvena, Lo Chew-Yong, Ho Hee-Hwa, Hausenloy Derek J., Tai Bee-Choo, Richards A. Mark, Chan Mark Y.
Funder
National Medical Research Council AstraZeneca
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Reference33 articles.
1. Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G et al (2017) Global, Regional, and National Burden of Cardiovascular Diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 70(1):1–25 2. Bonaca MP, Braunwald E, Sabatine MS (2015) Long-term use of Ticagrelor in patients with prior Myocardial Infarction. N Engl J Med 373(13):1274–1275 3. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045–1057 4. Van Giezen JJJ, Nilsson L, Berntsson P, Wissing B-M, Giordanetto F, Tomlinson W et al (2009) Ticagrelor binds to human P2Y12 independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation. J Thromb Haemost 7(9):1556–1565 5. Bae JP, Dobesh PP, Klepser DG, Anderson JD, Zagar AJ, McCollam PL et al (2012) Adherence and dosing frequency of common medications for cardiovascular patients. Am J Manag Care 18(3):139–146
|
|